Kaishun Hu

3.5k total citations · 2 hit papers
81 papers, 2.5k citations indexed

About

Kaishun Hu is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Kaishun Hu has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 19 papers in Oncology and 15 papers in Electrical and Electronic Engineering. Recurrent topics in Kaishun Hu's work include RNA modifications and cancer (16 papers), Ubiquitin and proteasome pathways (11 papers) and DNA Repair Mechanisms (10 papers). Kaishun Hu is often cited by papers focused on RNA modifications and cancer (16 papers), Ubiquitin and proteasome pathways (11 papers) and DNA Repair Mechanisms (10 papers). Kaishun Hu collaborates with scholars based in China, United States and Singapore. Kaishun Hu's co-authors include Wenjia Li, Qingfang Han, Wenlong Zhai, Jie Gao, Shuijun Zhang, Dong Yin, Yin Zhang, Tiebang Kang, Yi Sang and Haiyan Yan and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Kaishun Hu

77 papers receiving 2.5k citations

Hit Papers

Exosome biogenesis: machinery, regulation, and therapeuti... 2022 2026 2023 2024 2022 2024 100 200 300 400

Peers

Kaishun Hu
Tao Peng China
Tao Zhu China
Mayank Tandon United States
Jiang Cao China
Andrew Silver United Kingdom
Kathreena M. Kurian United Kingdom
Tao Peng China
Kaishun Hu
Citations per year, relative to Kaishun Hu Kaishun Hu (= 1×) peers Tao Peng

Countries citing papers authored by Kaishun Hu

Since Specialization
Citations

This map shows the geographic impact of Kaishun Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaishun Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaishun Hu more than expected).

Fields of papers citing papers by Kaishun Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaishun Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaishun Hu. The network helps show where Kaishun Hu may publish in the future.

Co-authorship network of co-authors of Kaishun Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaishun Hu. A scholar is included among the top collaborators of Kaishun Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaishun Hu. Kaishun Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Peng, Yuntan Qiu, Kaishun Hu, et al.. (2025). The SETDB1-PC4-UPF1 post-transcriptional machinery controls periodic degradation of CENPF mRNA and maintains mitotic progression. Cell Death and Differentiation. 32(8). 1413–1427. 1 indexed citations
2.
Deng, Yawen, et al.. (2025). Comprehensive dataset of interactors for the entire PARP family using TurboID proximity labeling. Scientific Data. 12(1). 405–405. 2 indexed citations
3.
Huang, Yongsheng, Yuntan Qiu, Sha Fu, et al.. (2024). Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study. The Journal of Pathology Clinical Research. 10(2). e12367–e12367. 3 indexed citations
4.
Wu, Weijun, Wenjing Wu, Qiao Yang, et al.. (2024). The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation. Journal of Biological Chemistry. 300(3). 105671–105671. 2 indexed citations
5.
Luo, Peng, et al.. (2024). Periodic changes of cyclin D1 mRNA stability are regulated by PC4 modifications in the cell cycle. The Journal of Cell Biology. 223(3). 2 indexed citations
6.
Li, Yun, Huafu Li, Xiancong Chen, et al.. (2024). NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 631(8021). 663–669. 260 indexed citations breakdown →
7.
Guo, Wenting, Weijun Wu, Yuan Gao, et al.. (2024). Structural insights into the catalytic mechanism of the AP endonuclease AtARP. Structure. 32(6). 780–794.e5. 1 indexed citations
8.
Qi, Fangfang, Zejie Zuo, Kaishun Hu, et al.. (2023). VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration. Molecular Psychiatry. 28(10). 4374–4389. 13 indexed citations
9.
Wang, Jianjun, Luyao Wang, Chengli Yang, et al.. (2023). Preparation of magnetic polyacrylamide hydrogel with chitosan for immobilization of glutamate decarboxylase to produce γ-aminobutyric acid. Preparative Biochemistry & Biotechnology. 54(1). 103–114. 2 indexed citations
10.
Deng, Yuefeng, Chengli Yang, Yihui Zhu, et al.. (2022). The effect of nano-calcium carbonate on β-glucosidase immobilized by alginate and chitosan. Green Synthesis and Catalysis. 3(3). 265–271. 6 indexed citations
11.
Qiu, Yuntan, Meng Meng, Jingyuan Zhang, et al.. (2021). RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma. Molecular Therapy — Nucleic Acids. 27. 241–255. 7 indexed citations
12.
Liao, Jian‐You, Bing Yang, Yu‐Chan Zhang, et al.. (2019). EuRBPDB: a comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs). Nucleic Acids Research. 48(D1). D307–D313. 71 indexed citations
13.
Hu, Kaishun, Yu Li, Wenjing Wu, et al.. (2018). High-performance gene expression and knockout tools using sleeping beauty transposon system. Mobile DNA. 9(1). 33–33. 20 indexed citations
14.
He, Jian, et al.. (2018). The diagnostic value of five serum tumor markers for patients with cholangiocarcinoma. Clinica Chimica Acta. 480. 186–192. 19 indexed citations
15.
Huang, Yumei, Kaishun Hu, Sheng Zhang, et al.. (2018). S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer. Theranostics. 8(5). 1286–1300. 34 indexed citations
16.
Guo, Yabin, Yin Zhang, & Kaishun Hu. (2018). Sleeping Beauty transposon integrates into non-TA dinucleotides. Mobile DNA. 9(1). 8–8. 8 indexed citations
17.
Huang, Pinbo, Baoxiong Zhuang, Heyun Zhang, et al.. (2015). Hepatitis B Virus X Protein (HBx) Is Responsible for Resistance to Targeted Therapies in Hepatocellular Carcinoma: Ex Vivo Culture Evidence. Clinical Cancer Research. 21(19). 4420–4430. 20 indexed citations
18.
Liao, Dan, Li Zhong, Ru-Hua Zhang, et al.. (2015). Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway. Clinical Cancer Research. 21(23). 5349–5359. 101 indexed citations
19.
Hu, Kaishun, et al.. (2011). Molecular Cloning and Expression Analysis of Transforming Growth Factorβ1(TGFβ1) from OrangeSpotted Grouper (Epinephelus coioides). Acta Scientiarum Naturalium Universitatis Sunyatseni. 50(1). 92. 3 indexed citations
20.
Hu, Kaishun, YE Bang-yan, & Weiping Wang. (2006). Study on the Open Modular Design Method of Products for Enterprise-Cluster Manufacturing. Journal of Kunming University of Science and Technology. 31(6). 36–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026